BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND PTPRK, DKFZp686C2268, 5796, ENSG00000152894, DKFZp779N1045, R-PTP-kappa, RP3-480J14_1
100242 results:

  • 1. Immunotherapy for esophageal cancer: Where are we now and where can we go.
    Shoji Y; Koyanagi K; Kanamori K; Tajima K; Ogimi M; Ninomiya Y; Yamamoto M; Kazuno A; Nabeshima K; Nishi T; Mori M
    World J Gastroenterol; 2024 May; 30(19):2496-2501. PubMed ID: 38817664
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical, histopathological characteristics and malignant transformation of proliferative verrucous leukoplakia with 36 patients: a retrospective longitudinal study.
    Zhang C; Lan Q; Wei P; Gao Y; Zhang J; Hua H
    BMC Oral Health; 2024 May; 24(1):639. PubMed ID: 38816724
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Risk of second primary thyroid cancer in cancer survivors.
    Yuan Y; Sun P; Xiao H; Li L; Li J; Ai X
    Sci Rep; 2024 May; 14(1):12478. PubMed ID: 38816510
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma.
    Li S; Liu Z; Chen Q; Chen Y; Ji S
    Sci Rep; 2024 May; 14(1):12476. PubMed ID: 38816411
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer.
    Chen CS; Luo SD; Chang YH; Chou CK; Chi SY; Wu SC; Chen YH; Yang JC; Huang EY; Wang YM; Lin WC
    Int J Hyperthermia; 2024; 41(1):2358054. PubMed ID: 38816274
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Thyroid Malignancy in Patients Who Underwent Thyroidectomy for Multinodular Goiter and Solitary Thyroid Nodule.
    Gedamu D; Shimels T; Kassie D; Chanyalew Z; Eyasu M
    JCO Glob Oncol; 2024 May; 10():e2300322. PubMed ID: 38815179
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinimetric Properties of the Chinese Short Form of the Sarcopenia Quality of Life Questionnaire in Patients With cancer.
    Liu H; Wang H; Dong M; Wang J; Wang Z; Su N; Shao D; Cui N; Cao F
    J Nurs Res; 2024 Jun; 32(3):e327. PubMed ID: 38814994
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Study on mechanism of inhibiting proliferation of head and neck cancer cells by citral, active ingredient of lemon essential oil].
    Chen L; Zhang YJ; Qin HW; Hu WJ; Liu YJ; Xiao GS; DU HH; Yang DL
    Zhongguo Zhong Yao Za Zhi; 2024 May; 49(9):2364-2375. PubMed ID: 38812137
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Lymph node metastasis in cutaneous squamous cell carcinoma of the head and neck.
    Fang Q; Yuan J; Zhang X; Dai L; Luo R
    BMC Cancer; 2024 May; 24(1):656. PubMed ID: 38811899
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The enhanced energy metabolism in the tumor margin mediated by RRAD promotes the progression of oral squamous cell carcinoma.
    Cheng A; Xu Q; Li B; Zhang L; Wang H; Liu C; Han Z; Feng Z
    Cell Death Dis; 2024 May; 15(5):376. PubMed ID: 38811531
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic Ability of Expression of Myofibroblasts in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Shete MV; Shete AV; Buva K; Channe PP; Sapkal R; Nerkar Rajbhoj A
    Asian Pac J Cancer Prev; 2024 May; 25(5):1477-1486. PubMed ID: 38809619
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Influence of maximum diameter on fine-needle aspiration biopsy outcomes in ACR TI-RADS 5 thyroid nodules.
    Cao SL; Shi WY; Niu YR; Zhao ZL; Wei Y; Wu J; Peng LL; Li Y; Yu MA
    Front Endocrinol (Lausanne); 2024; 15():1374888. PubMed ID: 38808118
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Meta-analyses of the relationship between five CXCL8 gene polymorphisms and overall cancer risk, and a case-control study of oral cancer.
    Peng J; Wang Y; Kuang D; Wang Y; Wu G; Li H; Li D; Cao H
    BMC Oral Health; 2024 May; 24(1):622. PubMed ID: 38807156
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma.
    Chen P; Fu C; Shen L; Fei Z; Luo M; Chen Y; Li H
    BMC Health Serv Res; 2024 May; 24(1):676. PubMed ID: 38807104
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cellular mechanisms mediating the anti-cancer effects of carnosol on gingiva carcinoma.
    Gassib N; Issa H; Loubaki L; Behaz S; Almutairi MH; Rouabhia M; Semlali A
    Sci Rep; 2024 May; 14(1):12266. PubMed ID: 38806527
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Donafenib as neoadjuvant therapy in locally advanced thyroid cancer: protocol for the DONATHYCA phase II prospective single-arm trial in China.
    Yu J; Liu H; Wu Y
    BMJ Open; 2024 May; 14(5):e081090. PubMed ID: 38806431
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial.
    Qiu MZ; Oh DY; Kato K; Arkenau T; Tabernero J; Correa MC; Zimina AV; Bai Y; Shi J; Lee KW; Wang J; Poddubskaya E; Pan H; Rha SY; Zhang R; Hirano H; Spigel D; Yamaguchi K; Chao Y; Wyrwicz L; Disel U; Cid RP; Fornaro L; Evesque L; Wang H; Xu Y; Li J; Sheng T; Yang S; Li L; Moehler M; Xu RH;
    BMJ; 2024 May; 385():e078876. PubMed ID: 38806195
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Our experience in the treatment of congenital nasal median heterotopias in children and an overview of various treatment tactics].
    Molodtsova EV; Yunusov AS; Daikhes NA; Polyakov DP; Korobkin AS; Larina OM
    Vestn Otorinolaringol; 2024; 89(2):28-32. PubMed ID: 38805460
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. No Change in Complications Following Thyroidectomy Despite Increase in Thyroid cancer Surgeries: A Meta-Regression Analysis.
    Lee JS; Lee JS; Yun HJ; Kim SM; Chang H; Lee YS; Yang J; Lee HS; Chang HS
    Yonsei Med J; 2024 Jun; 65(6):348-355. PubMed ID: 38804029
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Long-Term Changes of Urinary Exosomal Peptide Levels After Thyroidectomy in Patients with Thyroid cancer: A
    Wang CY; Shih SR; Chen KY; Chung YC; Huang PJ
    Int J Nanomedicine; 2024; 19():4667-4677. PubMed ID: 38803995
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5013.